Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 823

1.

Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial.

Nickel JC, Roehrborn CG, O'leary MP, Bostwick DG, Somerville MC, Rittmaster RS.

J Urol. 2007 Sep;178(3 Pt 1):896-900; discussion 900-1. Epub 2007 Jul 16.

PMID:
17632164
[PubMed - indexed for MEDLINE]
2.

Dutasteride reduces prostatitis symptoms compared with placebo in men enrolled in the REDUCE study.

Nickel JC, Roehrborn C, Montorsi F, Wilson TH, Rittmaster RS.

J Urol. 2011 Oct;186(4):1313-8. doi: 10.1016/j.juro.2011.05.071. Epub 2011 Aug 17.

PMID:
21849186
[PubMed - indexed for MEDLINE]
3.

Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial.

Andriole G, Bostwick D, Brawley O, Gomella L, Marberger M, Tindall D, Breed S, Somerville M, Rittmaster R; REDUCE Study Group.

J Urol. 2004 Oct;172(4 Pt 1):1314-7.

PMID:
15371831
[PubMed - indexed for MEDLINE]
4.

Improvements in benign prostatic hyperplasia-specific quality of life with dutasteride, the novel dual 5alpha-reductase inhibitor.

O'Leary MP, Roehrborn C, Andriole G, Nickel C, Boyle P, Höfner K.

BJU Int. 2003 Aug;92(3):262-6.

PMID:
12887480
[PubMed - indexed for MEDLINE]
5.

Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial.

Nickel JC, Downey J, Johnston B, Clark J; Canadian Prostatitis Research Group.

J Urol. 2001 May;165(5):1539-44.

PMID:
11342913
[PubMed - indexed for MEDLINE]
6.

The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial.

Nickel JC, Roehrborn CG, O'Leary MP, Bostwick DG, Somerville MC, Rittmaster RS.

Eur Urol. 2008 Dec;54(6):1379-84. Epub 2007 Nov 20.

PMID:
18036719
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Symptoms suggestive of chronic pelvic pain syndrome in an urban population: prevalence and associations with lower urinary tract symptoms and erectile function.

Marszalek M, Wehrberger C, Hochreiter W, Temml C, Madersbacher S.

J Urol. 2007 May;177(5):1815-9.

PMID:
17437827
[PubMed - indexed for MEDLINE]
8.

Efficacy and safety of dutasteride in the four-year treatment of men with benign prostatic hyperplasia.

Roehrborn CG, Marks LS, Fenter T, Freedman S, Tuttle J, Gittleman M, Morrill B, Wolford ET.

Urology. 2004 Apr;63(4):709-15.

PMID:
15072886
[PubMed - indexed for MEDLINE]
9.

Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index.

Nickel JC, Downey J, Hunter D, Clark J.

J Urol. 2001 Mar;165(3):842-5.

PMID:
11176483
[PubMed - indexed for MEDLINE]
10.

Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: secondary analysis of the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.

Roehrborn CG, Nickel JC, Andriole GL, Gagnier RP, Black L, Wilson TH, Rittmaster RS.

Urology. 2011 Sep;78(3):641-6. doi: 10.1016/j.urology.2011.03.063. Epub 2011 Jul 20.

PMID:
21764428
[PubMed - indexed for MEDLINE]
11.

Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.

Mehik A, Alas P, Nickel JC, Sarpola A, Helström PJ.

Urology. 2003 Sep;62(3):425-9.

PMID:
12946740
[PubMed - indexed for MEDLINE]
12.

Effect of dutasteride on the risk of prostate cancer.

Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall DJ, Somerville MC, Wilson TH, Fowler IL, Rittmaster RS; REDUCE Study Group.

N Engl J Med. 2010 Apr 1;362(13):1192-202. doi: 10.1056/NEJMoa0908127.

PMID:
20357281
[PubMed - indexed for MEDLINE]
Free Article
13.

Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial.

Cheah PY, Liong ML, Yuen KH, Teh CL, Khor T, Yang JR, Yap HW, Krieger JN.

J Urol. 2003 Feb;169(2):592-6.

PMID:
12544314
[PubMed - indexed for MEDLINE]
14.

The effect of dutasteride on the peripheral and transition zones of the prostate and the value of the transition zone index in predicting treatment response.

Marks LS, Roehrborn CG, Wolford E, Wilson TH.

J Urol. 2007 Apr;177(4):1408-13.

PMID:
17382742
[PubMed - indexed for MEDLINE]
15.

Delay in the progression of low-risk prostate cancer: rationale and design of the Reduction by Dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trial.

Fleshner N, Gomella LG, Cookson MS, Finelli A, Evans A, Taneja SS, Lucia MS, Wolford E, Somerville MC, Rittmaster R; REDEEM Study Group.

Contemp Clin Trials. 2007 Nov;28(6):763-9. Epub 2007 May 29.

PMID:
17573244
[PubMed - indexed for MEDLINE]
16.
17.

Pentosan polysulfate therapy for chronic nonbacterial prostatitis (chronic pelvic pain syndrome category IIIA): a prospective multicenter clinical trial.

Nickel JC, Johnston B, Downey J, Barkin J, Pommerville P, Gregoire M, Ramsey E.

Urology. 2000 Sep 1;56(3):413-7.

PMID:
10962305
[PubMed - indexed for MEDLINE]
18.

Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study.

Schaeffer AJ, Knauss JS, Landis JR, Propert KJ, Alexander RB, Litwin MS, Nickel JC, O'Leary MP, Nadler RB, Pontari MA, Shoskes DA, Zeitlin SI, Fowler JE Jr, Mazurick CA, Kusek JW, Nyberg LM; Chronic Prostatitis Collaborative Research Network Study Group.

J Urol. 2002 Sep;168(3):1048-53.

PMID:
12187220
[PubMed - indexed for MEDLINE]
19.

Predictors of quality of life and pain in chronic prostatitis/chronic pelvic pain syndrome: findings from the National Institutes of Health Chronic Prostatitis Cohort Study.

Tripp DA, Curtis Nickel J, Landis JR, Wang YL, Knauss JS; CPCRN Study Group.

BJU Int. 2004 Dec;94(9):1279-82.

PMID:
15610105
[PubMed - indexed for MEDLINE]
20.

Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia.

Andriole GL, Roehrborn C, Schulman C, Slawin KM, Somerville M, Rittmaster RS.

Urology. 2004 Sep;64(3):537-41; discussion 542-3.

PMID:
15351586
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk